Evidence map›Paper›PMID 26893378›Full record

ArticleThe Journal of biological chemistry2016

The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.

Garima Singh, Jingwen Zhang, Yilun Ma, Richard A Cerione, Marc A Antonyak

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Impact ofInternational journal of molecular sciences · 2023
    Article
  9. Review
  10. Article
  11. Evolving Experimental Techniques for Structure-Based Drug Design.The journal of physical chemistry. B · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Garima SinghFrom the Department of Molecular Medicine and.
Jingwen ZhangFrom the Department of Molecular Medicine and.
Yilun MaFrom the Department of Molecular Medicine and.
Richard A CerioneFrom the Department of Molecular Medicine and the Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853 rac1@cornell.edu.
Marc A AntonyakFrom the Department of Molecular Medicine and.
Cornell University · US

Funding

Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
RECONSTITUTION OF GROWTH FACTOR RECEPTOR/TYROSINE KINASER01GM040654 · NIGMS · CORNELL UNIVERSITY ITHACA · PI CERIONE, RICHARD A. · 1988 to 2016
$5.6M
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancersR01CA201402 · NCI · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2016 to 2024
$4.3M
NCI NIH HHS R01 CA201402NIGMS NIH HHS P41 GM103485NIGMS NIH HHS R01 GM040654
6 · The paper itself

Abstract

Tissue transglutaminase (tTG) is an acyltransferase/GTP-binding protein that contributes to the development of various diseases. In human cancer cells, tTG activates signaling pathways that promote cell growth and survival, whereas in other disorders (i.e. neurodegeneration), overexpression of tTG enhances cell death. Therefore, it is important to understand how tTG is differentially regulated and functioning to promote diametrically distinct cellular outcomes. Previous structural studies revealed that tTG adopts either a nucleotide-bound closed conformation or a transamidation-competent open conformation. Here we provide evidence showing that these different conformational states determine whether tTG promotes, or is detrimental to, cell survival, with the open conformation of the protein being responsible for inducing cell death. First, we demonstrate that a nucleotide binding-defective form of tTG, which has previously been shown to induce cell death, assumes an open conformation in solution as assessed by an enhanced sensitivity to trypsin digestion and by small angle x-ray scattering (SAXS) analysis. We next identify two pairs of intramolecular hydrogen bonds that, based on existing x-ray structures, are predicted to form between the most C-terminal β-barrel domain and the catalytic core domain of tTG. By disrupting these hydrogen bonds, we are able to generate forms of tTG that constitutively assume an open conformation and induce apoptosis. These findings provide important insights into how tTG participates in the pathogenesis of neurodegenerative diseases, particularly with regard to the actions of a C-terminal truncated form of tTG (TG-Short) that has been linked to such disorders and induces apoptosis by assuming an open-like conformation.

Indexed as

ApoptosisGTP-Binding ProteinsNeurodegenerative DiseasesTransglutaminasesAnimalsCell SurvivalHumansMiceNIH 3T3 CellsProtein Glutamine gamma Glutamyltransferase 2Protein Structure, SecondaryProtein Structure, TertiaryGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminasesapoptosiscell deathconformational changeprotein cross-linkingsmall-angle x-ray scattering (SAXS)transglutaminase

Identifiers

PMID26893378
PMCPMC4861479
OpenAlexW2277922850

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.